USA antimicrobial susceptibility testing market is characterized by the presence of leading diagnostics and life sciences companies focused on delivering rapid, reliable, and scalable solutions.

A randomized trial involving gram-negative bacterial bloodstream infections found that rapid antibiotic susceptibility testing (AST) was not superior to usual testing in terms of clinical outcomes.

McGill researchers have developed a diagnostic system capable of identifying bacteria—and determining which antibiotics can stop them—in just 36 minutes, a major advance in the global effort to curb ...

The US Food and Drug Administration (FDA) on Wednesday launched a new website aimed at improving access to information that can help healthcare professionals determine which drugs are most likely to ...

Researchers at the University of Pennsylvania have developed ApexGO, a novel, AI-powered method for turning promising but ...

A recent Lancet Microbe study investigated the accuracy of antibiotic resistance determination from Enterococcus faecium genomes for diagnostic purposes. Study: Antibiotic resistance determination ...

Sepsis remains a substantial disease burden worldwide, and patients can deteriorate rapidly, but the current diagnostics take ...

Researchers have presented a new method for measuring how effectively antibiotics kill bacteria. Antibiotic-resistant bacteria are one of the biggest health problems of our time. Due to mutations, ...

Shanx Medtech BV raised €15 million (US$17.5 million) in a seed funding round for its in vitro diagnostic platform for ultra-rapid antimicrobial susceptibility testing. The financing came from a range ...

Applying a Novel Microplate Photometer for the Assessment of Bacterial Growth As commonly prescribed treatments for bacterial infection, antibiotics are substances or compounds that kill (bactericidal ...